loadpatents
name:-0.0039620399475098
name:-0.0021388530731201
name:-0.0017502307891846
BELLO; Carlo Leonel Patent Filings

BELLO; Carlo Leonel

Patent Applications and Registrations

Patent applications and USPTO patent grants for BELLO; Carlo Leonel.The latest application filed is for "dosing regimen of avelumab for the treatment of cancer".

Company Profile
1.1.3
  • BELLO; Carlo Leonel - San Francisco CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Dosing Regimen Of Avelumab For The Treatment Of Cancer
App 20220220205 - Andrews; Glen Ian ;   et al.
2022-07-14
Dosing regimen of avelumab for the treatment of cancer
Grant 11,274,154 - Andrews , et al. March 15, 2
2022-03-15
Dosing Regimen of Avelumab for the Treatment of Cancer
App 20190330352 - Andrews; Glen Ian ;   et al.
2019-10-31
Method of treating abnormal cell growth using indolinone compounds
App 20050182122 - Bello, Carlo Leonel ;   et al.
2005-08-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed